MX2023015246A - Compuestos pirimidinicos para usar como inhibidores de map4k1. - Google Patents

Compuestos pirimidinicos para usar como inhibidores de map4k1.

Info

Publication number
MX2023015246A
MX2023015246A MX2023015246A MX2023015246A MX2023015246A MX 2023015246 A MX2023015246 A MX 2023015246A MX 2023015246 A MX2023015246 A MX 2023015246A MX 2023015246 A MX2023015246 A MX 2023015246A MX 2023015246 A MX2023015246 A MX 2023015246A
Authority
MX
Mexico
Prior art keywords
compounds
map4k1
pyrimidinic
inhibitors
map4k1 inhibitors
Prior art date
Application number
MX2023015246A
Other languages
English (en)
Spanish (es)
Inventor
Sandip Patil
Sanjib Das
Pravin Iyer
Murugan Chinnapattu
Nagaraj Gowda
Chandrasekhar Misra
Sachin Chaudhari
Jagmohan Saini
Sravan Mandadi
Dnyaneshwar Dahale
Nanasaheb Kadlag
Priyanka Pangare
Original Assignee
Glenmark Specialty Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Specialty Sa filed Critical Glenmark Specialty Sa
Publication of MX2023015246A publication Critical patent/MX2023015246A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2023015246A 2021-07-06 2022-07-06 Compuestos pirimidinicos para usar como inhibidores de map4k1. MX2023015246A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202121030204 2021-07-06
PCT/IB2022/056248 WO2023281417A1 (en) 2021-07-06 2022-07-06 Pyrimidine compounds for use as map4k1 inhibitors

Publications (1)

Publication Number Publication Date
MX2023015246A true MX2023015246A (es) 2024-01-19

Family

ID=82703212

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023015246A MX2023015246A (es) 2021-07-06 2022-07-06 Compuestos pirimidinicos para usar como inhibidores de map4k1.

Country Status (14)

Country Link
US (1) US12577267B2 (https=)
EP (1) EP4367123A1 (https=)
JP (1) JP2024527565A (https=)
KR (1) KR20240012538A (https=)
CN (1) CN117730083A (https=)
AU (1) AU2022305807B2 (https=)
CA (1) CA3223874A1 (https=)
CL (1) CL2023003791A1 (https=)
CO (1) CO2024000572A2 (https=)
EC (1) ECSP24007193A (https=)
IL (1) IL309342A (https=)
MX (1) MX2023015246A (https=)
PE (1) PE20240585A1 (https=)
WO (1) WO2023281417A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024231875A1 (en) 2023-05-09 2024-11-14 Glenmark Specialty S.A. Hpk1 inhibitor for use in the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2792979T3 (es) * 2013-08-22 2020-11-12 Jubilant Biosys Ltd Compuestos de pirimidina sustituidos, composiciones y aplicaciones médicas de los mismos
WO2018102366A1 (en) * 2016-11-30 2018-06-07 Ariad Pharmaceuticals, Inc. Anilinopyrimidines as haematopoietic progenitor kinase 1 (hpk1) inhibitors
AU2020406824A1 (en) * 2019-12-16 2022-08-11 Korea Research Institute Of Chemical Technology Novel pyrimidine derivative and use thereof

Also Published As

Publication number Publication date
AU2022305807A1 (en) 2024-01-04
AU2022305807B2 (en) 2024-09-05
JP2024527565A (ja) 2024-07-25
US20230227483A1 (en) 2023-07-20
CN117730083A (zh) 2024-03-19
US12577267B2 (en) 2026-03-17
WO2023281417A1 (en) 2023-01-12
CA3223874A1 (en) 2023-01-12
PE20240585A1 (es) 2024-03-21
CL2023003791A1 (es) 2024-07-12
CO2024000572A2 (es) 2024-02-05
IL309342A (en) 2024-02-01
KR20240012538A (ko) 2024-01-29
ECSP24007193A (es) 2024-03-01
EP4367123A1 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
MX2023007192A (es) Inhibidores de prmt5.
JOP20230113A1 (ar) مشتقات ثلاثية الكربوكساميد كمثبطات prmt5
CO2024005925A2 (es) Moléculas pequeñas para el tratamiento del cáncer
MX376584B (es) Compuestos de derivados de 1,3,4-oxadiazolsulfonamida como inhibidor de histona desacetilasa 6, y la composición farmacéutica que comprende los mismos
JOP20240165A1 (ar) مشتقات بيبريدينيل سبيرو سيكليك كمثبطات عامل مكمل b واستخداماتها
JOP20200315A1 (ar) مركبات بورينون واستخدامها في معالجة السرطان
CY1125488T1 (el) Παραγωγα πυριδινης και θεραπευτικες χρησεις αυτων ως αναστολεις trpc6
TW201612158A (en) Amide derivatives and salts thereof, preparation process and pharmaceutical use thereof
EA201691803A1 (ru) Ингибиторы калликреина плазмы человека
NO20090723L (no) Kondenserte heterosykliske derivater og fremgangsmater for anvendelse
PH12021550742A1 (en) Indolinone compounds for use as map4k1 inhibitors
EA201291099A1 (ru) Новые иммуномодуляторные и противовоспалительные соединения
EA201001159A1 (ru) Конденсированные гетероциклические производные и их применение
BR112015028879A8 (pt) compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos
EA201071040A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40
EA202192433A1 (ru) Соединения, полезные в терапии вич
DK2105164T3 (da) Nye P2X7R-antagonister og deres anvendelse
EA201071043A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1
MX2020001531A (es) Nuevos compuestos hetorociclicos como inhibidores de cdk8/19.
JOP20200100A1 (ar) مشتقات بيرازولو-بيرولو-بيريميدين-ديون جديدة كمثبِّطات لـ p2x3
MX2025001865A (es) Compuestos de piridinona sustituida como inhibidores de cbl-b
ATE540038T1 (de) Heterocyclen als proteinkinaseinhibitoren
MX2021015873A (es) Un derivado de tetrahidroisoquinolina sustituido como modulador alosterico positivo de d1.
PH12022552727A1 (en) COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF HIF2a AND THEIR METHODS OF USE
SA522441650B1 (ar) مثبطات فوسفوينوسيتيد 3-كيناز الموضعية